Photocure ASA

AGM Information • Apr 27, 2017

Photocure ASA: Annual general meeting held

Photocure ASA: Annual general meeting held

Oslo, 27 April 2017: Photocure ASA (OSE: PHO), held its annual general meeting

on 27 April 2017 at 17:00 hours (CET).

All proposals were resolved as presented in the notice convening the general

meeting dated 5 April 2016, as further set out in the minutes from the general

meeting attached hereto.

For further information, please contact:

Photocure

CFO Erik Dahl

Tel: +47 450 55 000, Email: ed@photocure.no

About Photocure ASA

Photocure, headquartered in Oslo Norway, is a specialty pharmaceutical company

and world leader in photodynamic technology. As a commercial stage company

focused on the urology market, Photocure's proprietary technology provides

improved detection and management of bladder cancer.  Our aim is to provide

solutions which can improve health outcomes for patients worldwide. Photocure is

listed on the Oslo Stock Exchange (OSE: PHO). Information about Photocure is

available at www.photocure.com.

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.